Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer

One factor contributing to the malignancy of cancer cells is the acquisition of drug resistance during chemotherapy via increased expression of efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP). These tran...

Full description

Bibliographic Details
Main Authors: Takuo Ogihara, Kenta Mizoi, Hiroki Kamioka, Kentaro Yano
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/11/3352
id doaj-92c7dde4b02444c5bbfc6b43d15132b3
record_format Article
spelling doaj-92c7dde4b02444c5bbfc6b43d15132b32020-11-25T04:06:01ZengMDPI AGCancers2072-66942020-11-01123352335210.3390/cancers12113352Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in CancerTakuo Ogihara0Kenta Mizoi1Hiroki Kamioka2Kentaro Yano3Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, 60, Nakaorui-machi, Takasaki, Gunma 370-0033, JapanFaculty of Pharmacy, Takasaki University of Health and Welfare, 60, Nakaorui-machi, Takasaki, Gunma 370-0033, JapanGraduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, 60, Nakaorui-machi, Takasaki, Gunma 370-0033, JapanFaculty of Pharmacy, Takasaki University of Health and Welfare, 60, Nakaorui-machi, Takasaki, Gunma 370-0033, JapanOne factor contributing to the malignancy of cancer cells is the acquisition of drug resistance during chemotherapy via increased expression of efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP). These transporters operate at the cell membrane, and are anchored in place by the scaffold proteins ezrin (Ezr), radixin (Rdx), and moesin (Msn) (ERM proteins), which regulate their functional activity. The identity of the regulatory scaffold protein(s) differs depending upon the transporter, and also upon the tissue in which it is expressed, even for the same transporter. Another factor contributing to malignancy is metastatic ability. Epithelial–mesenchymal transition (EMT) is the first step in the conversion of primary epithelial cells into mesenchymal cells that can be transported to other organs via the blood. The SNAI family of transcriptional regulators triggers EMT, and SNAI expression is used is an indicator of malignancy. Furthermore, EMT has been suggested to be involved in drug resistance, since drug excretion from cancer cells is promoted during EMT. We showed recently that ERM proteins are induced by a member of the SNAI family, Snail. Here, we first review recent progress in research on the relationship between efflux transporters and scaffold proteins, including the question of tissue specificity. In the second part, we review the relationship between ERM scaffold proteins and the transcriptional regulatory factors that induce their expression.https://www.mdpi.com/2072-6694/12/11/3352efflux transportersERM proteinstranscriptional regulatorsSNAI familyepithelial–mesenchymal transitionmembrane expression
collection DOAJ
language English
format Article
sources DOAJ
author Takuo Ogihara
Kenta Mizoi
Hiroki Kamioka
Kentaro Yano
spellingShingle Takuo Ogihara
Kenta Mizoi
Hiroki Kamioka
Kentaro Yano
Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
Cancers
efflux transporters
ERM proteins
transcriptional regulators
SNAI family
epithelial–mesenchymal transition
membrane expression
author_facet Takuo Ogihara
Kenta Mizoi
Hiroki Kamioka
Kentaro Yano
author_sort Takuo Ogihara
title Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_short Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_full Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_fullStr Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_full_unstemmed Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer
title_sort physiological roles of erm proteins and transcriptional regulators in supporting membrane expression of efflux transporters as factors of drug resistance in cancer
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-11-01
description One factor contributing to the malignancy of cancer cells is the acquisition of drug resistance during chemotherapy via increased expression of efflux transporters, such as P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP). These transporters operate at the cell membrane, and are anchored in place by the scaffold proteins ezrin (Ezr), radixin (Rdx), and moesin (Msn) (ERM proteins), which regulate their functional activity. The identity of the regulatory scaffold protein(s) differs depending upon the transporter, and also upon the tissue in which it is expressed, even for the same transporter. Another factor contributing to malignancy is metastatic ability. Epithelial–mesenchymal transition (EMT) is the first step in the conversion of primary epithelial cells into mesenchymal cells that can be transported to other organs via the blood. The SNAI family of transcriptional regulators triggers EMT, and SNAI expression is used is an indicator of malignancy. Furthermore, EMT has been suggested to be involved in drug resistance, since drug excretion from cancer cells is promoted during EMT. We showed recently that ERM proteins are induced by a member of the SNAI family, Snail. Here, we first review recent progress in research on the relationship between efflux transporters and scaffold proteins, including the question of tissue specificity. In the second part, we review the relationship between ERM scaffold proteins and the transcriptional regulatory factors that induce their expression.
topic efflux transporters
ERM proteins
transcriptional regulators
SNAI family
epithelial–mesenchymal transition
membrane expression
url https://www.mdpi.com/2072-6694/12/11/3352
work_keys_str_mv AT takuoogihara physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer
AT kentamizoi physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer
AT hirokikamioka physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer
AT kentaroyano physiologicalrolesofermproteinsandtranscriptionalregulatorsinsupportingmembraneexpressionofeffluxtransportersasfactorsofdrugresistanceincancer
_version_ 1724432958720311296